SCHEMBL20705487

SCHEMBL20705487

Cc1ccc(-c2ccc(-c3ccc(C(N)=O)cc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA12 O43570 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
KIF11 P52732 1/20 0.55
PARP10 Q53GL7 2/20 0.55
DHODH Q02127 1/20 0.54
ALDH1A1 P00352 2/20 0.54
LMNA P02545 1/20 0.54
CES2 O00748 1/20 0.54
CES1 P23141 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
MKNK1 Q9BUB5 6/20 0.52
MKNK2 Q9HBH9 6/20 0.52
BRD4 O60885 1/20 0.51
BRD9 Q9H8M2 1/20 0.51
MAPK1 P28482 1/20 0.51
MAP2K4 P45985 1/20 0.51
MAPKAPK2 P49137 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5981249 1.00 CA1 (0.55) CA1CA2CA12CA9CA14
Terephthalamide SCHEMBL17907469 0.93 ALDH1A1 (0.62) CA1CA2PARP10ALDH1A1LMNA
SCHEMBL76475 0.93 ALDH1A1 (0.62) CA1CA2PARP10ALDH1A1LMNA
SCHEMBL30775329 0.90 ALDH1A1 (0.59) CA1CA2PARP10ALDH1A1LMNA
SCHEMBL10416433 0.90 ALDH1A1 (0.59) CA1CA2PARP10ALDH1A1LMNA
Hydrazine SCHEMBL28484381 0.90 ALDH1A1 (0.59) CA1CA2PARP10ALDH1A1LMNA
Hydrochloric Acid SCHEMBL4376615 0.90 ALDH1A1 (0.59) CA1CA2PARP10ALDH1A1LMNA
Hydrochloric Acid SCHEMBL1776305 0.90 ALDH1A1 (0.59) CA1CA2PARP10ALDH1A1LMNA
Hydrochloric Acid SCHEMBL4879563 0.88 ALDH1A1 (0.56) CA1CA2PARP10ALDH1A1LMNA
Benzene SCHEMBL28164652 0.88 PARP1 (0.64) CA1CA2PARP10DHODHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196373-B2 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2019-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196373-B2 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein STAT3, STAT1, STAT4 CA1 2562/4885CA2 389/4885CA12 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.